Difference Between Patient Vaccine Hesitancy and Perception by Their Family Physician of Their Vaccine Hesitancy (DiffHésiVac)

The investigators will ask to a patient and his/her family physician to complete in parallel a brief questionnaire at the beginning of the consultation:

• for the patient: self-evaluation of his/her vaccine hesitancy (with a 0-100 scale)
• for the physician: evaluation of this patient vaccine hesitancy (on the same 0-100 scale) Each of these 2 questionnaires should be filled blindly from the other.

Study Overview

• Status: Unknown
• Conditions: Vaccine Hesitancy
• Intervention / Treatment: Other: questionnaire

Detailed Description

The investigators will ask to a patient and his/her family physician to complete in parallel a brief questionnaire at the beginning of the consultation:

• for the patient: self-evaluation of his/her vaccine hesitancy (with a 0-100 scale)
• for the physician: evaluation of this patient vaccine hesitancy (on the same 0-100 scale) Each of these 2 questionnaires should be filled blindly from the other.

The investigators will recruit 400 to 500 patients in 20 medical practices of general practioners.

• Study Type: Observational
• Enrollment (Anticipated): 400

Contacts and Locations

Study Locations

• France
  • Grenoble, France, 38000
    • Recruiting
    • EPAULARD
    • Contact: Olivier Epaulard, MD, PhD; Phone Number: +336476765291; Email: oepaulard@chu-grenoble.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

patients visiting their family physician in one participating medical practice

Description

Inclusion Criteria:

• visiting the family physician
• accepting the study after information

Exclusion Criteria:

• none apart from the reverse of inclusion criteria

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
unique group; patients visiting their family physician	Other: questionnaire; no intervention at all apart from filling a brief questionnaire; Other Names: no intervention at all apart from filling a brief questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
difference between patient's vaccine hesitancy and perception by his/her family physician of his/her vaccine hesitancy.	Each participant will evaluate hi/her vaccine hesitancy on a 0-100 scale; his/her family physician will also evaluate the vaccine hesitancy of this participant on the same 0-100 scale. The outcome 1 is the difference between patient's vaccine hesitancy and perception by his/her family physician of his/her vaccine hesitancy (on this 0-100 scale). These are arbitrary units.	one day

Collaborators and Investigators

• Sponsor: University Hospital, Grenoble

Study record dates

Study Major Dates

• Study Start (Actual): February 14, 2020
• Primary Completion (Anticipated): December 31, 2020
• Study Completion (Anticipated): December 31, 2020

Study Registration Dates

• First Submitted: January 14, 2020
• First Submitted That Met QC Criteria: March 17, 2020
• First Posted (Actual): March 18, 2020

Study Record Updates

• Last Update Posted (Actual): March 18, 2020
• Last Update Submitted That Met QC Criteria: March 17, 2020
• Last Verified: March 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: 38RC19.288; 2019-A02487-50 (Other Identifier: ID RCB)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: non sharing of individual data.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No